These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16887680)

  • 1. An in vitro time-kill assessment of linezolid and anaerobic bacteria.
    Yagi BH; Zurenko GE
    Anaerobe; 2003 Feb; 9(1):1-3. PubMed ID: 16887680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteria.
    Yagi BH; Zurenko GE
    Anaerobe; 1997 Oct; 3(5):301-6. PubMed ID: 16887605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    J Antimicrob Chemother; 2005 Jun; 55(6):1024-8. PubMed ID: 15824092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
    Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
    Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
    Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of linezolid against clinical isolates of Fusobacterium spp.
    Daeschlein G; Hoehne C; Assadian O; Daxboeck F; Meinl C; Kramer A; Kekulé AS
    J Antimicrob Chemother; 2006 Oct; 58(4):789-93. PubMed ID: 16905529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study.
    Boyanova L; Vladimir Djambazov ; Gergova G; Dragomir Iotov ; Petrov D; Osmanliev D; Minchev Z; Mitov I
    Anaerobe; 2004 Oct; 10(5):261-7. PubMed ID: 16701526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens.
    Alou L; Giménez MJ; Manso F; Sevillano D; Torrico M; González N; Granizo JJ; Bascones A; Prieto J; Maestre JR; Aguilar L
    Int J Antimicrob Agents; 2009 May; 33(5):449-52. PubMed ID: 19097755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):300-4. PubMed ID: 19501791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
    Ross JE; Fritsche TR; Sader HS; Jones RN
    Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
    Finegold SM; John SS; Vu AW; Li CM; Molitoris D; Song Y; Liu C; Wexler HM
    Anaerobe; 2004 Aug; 10(4):205-11. PubMed ID: 16701520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci.
    Citron DM; Kwok YY; Appleman MD
    Anaerobe; 2005; 11(1-2):93-5. PubMed ID: 16701537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies.
    Werner H; Schädler G; Krasemann C
    Arzneimittelforschung; 1983; 33(4):574-7. PubMed ID: 6683537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activities of a novel oxazolidinone, OCID0050.
    Paul-Satyaseela M; Solanki SS; Sathishkumar D; Bharani T; Magesh V; Rajagopal S
    J Antimicrob Chemother; 2009 Oct; 64(4):797-800. PubMed ID: 19689978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro activity of trospectomycin against anaerobic bacteria.
    Chisari G; Lo Bue AM; Nicoletti G
    J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
    Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
    Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
    Ednie LM; Credito KL; Khantipong M; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2000 May; 45(5):633-8. PubMed ID: 10797085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.